CY1110248T1 - Μεθοδοι ελεγχου ποιοτητας για γαλακτωματα ελαιου εντος υδατος που περιεχουν σκουaλενιο - Google Patents

Μεθοδοι ελεγχου ποιοτητας για γαλακτωματα ελαιου εντος υδατος που περιεχουν σκουaλενιο

Info

Publication number
CY1110248T1
CY1110248T1 CY20091101322T CY091101322T CY1110248T1 CY 1110248 T1 CY1110248 T1 CY 1110248T1 CY 20091101322 T CY20091101322 T CY 20091101322T CY 091101322 T CY091101322 T CY 091101322T CY 1110248 T1 CY1110248 T1 CY 1110248T1
Authority
CY
Cyprus
Prior art keywords
oil
quality control
methods
water containing
containing sequence
Prior art date
Application number
CY20091101322T
Other languages
English (en)
Inventor
Norbert Klein
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37594567&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1110248(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CY1110248T1 publication Critical patent/CY1110248T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/21—Hydrocarbon
    • Y10T436/214—Acyclic [e.g., methane, octane, isoparaffin, etc.]
    • Y10T436/216—Unsaturated [e.g., ethylene, diene, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Edible Oils And Fats (AREA)
  • Colloid Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • General Factory Administration (AREA)
  • Steering-Linkage Mechanisms And Four-Wheel Steering (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)

Abstract

Μετρήσεις του περιεχομένου σκουαλενίου εντός γαλακτωμάτων ελαίου εντός ύδατος μπορούν να χρησιμοποιηθούν ως τρόπος ελέγχου για προβλήματα κατά τη διάρκεια της παραγωγής. Ειδικότερα βρέθηκε ότι η πτώση του περιεχομένου σκουαλενίου μπορεί να αποτελέσει ένδειξη προβλημάτων διήθησης. Η εξέταση του περιεχομένου σκουαλενίου στις τελικές παρτίδες είναι ευκολότερη σε σχέση με τη διερεύνηση των χαρακτηριστικών του φίλτρου, και έτσι η οποιαδήποτε ανάλυση σκουαλενίου απλοποιεί τον έλεγχο ποιότητας σε γαλακτώματα ελαίου εντός ύδατος.
CY20091101322T 2006-11-08 2009-12-21 Μεθοδοι ελεγχου ποιοτητας για γαλακτωματα ελαιου εντος υδατος που περιεχουν σκουaλενιο CY1110248T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0622282.2A GB0622282D0 (en) 2006-11-08 2006-11-08 Quality control methods
EP07859275A EP2029170B1 (en) 2006-11-08 2007-11-06 Quality control methods for oil-in-water emulsions containing squalene

Publications (1)

Publication Number Publication Date
CY1110248T1 true CY1110248T1 (el) 2015-01-14

Family

ID=37594567

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091101322T CY1110248T1 (el) 2006-11-08 2009-12-21 Μεθοδοι ελεγχου ποιοτητας για γαλακτωματα ελαιου εντος υδατος που περιεχουν σκουaλενιο

Country Status (26)

Country Link
US (2) US8562943B2 (el)
EP (2) EP2029170B1 (el)
JP (1) JP2010509202A (el)
KR (1) KR20090083448A (el)
CN (1) CN101534856A (el)
AT (1) ATE446770T1 (el)
AU (1) AU2007319006B2 (el)
BR (1) BRPI0718858A2 (el)
CA (1) CA2668854C (el)
CY (1) CY1110248T1 (el)
DE (1) DE602007003021D1 (el)
DK (1) DK2029170T3 (el)
EA (1) EA200900665A1 (el)
ES (1) ES2335160T3 (el)
GB (1) GB0622282D0 (el)
HK (1) HK1126148A1 (el)
HR (1) HRP20100046T1 (el)
IL (1) IL198084A0 (el)
MX (1) MX2009004697A (el)
NO (1) NO20092137L (el)
PL (1) PL2029170T3 (el)
PT (1) PT2029170E (el)
RS (1) RS51214B (el)
SI (1) SI2029170T1 (el)
WO (1) WO2008056263A2 (el)
ZA (1) ZA200902870B (el)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0622282D0 (en) * 2006-11-08 2006-12-20 Novartis Ag Quality control methods
WO2009158395A1 (en) * 2008-06-25 2009-12-30 Braasch Biotech Llc Compositions and methods for enhanced somatostatin immunogenicity
AU2009286426B2 (en) * 2008-08-28 2013-08-22 Novartis Ag Production of squalene from hyper-producing yeasts
WO2010103022A2 (en) * 2009-03-12 2010-09-16 Sanofi Pasteur Oil-in-water adjuvanted influenza vaccine
EA025622B1 (ru) 2009-12-03 2017-01-30 Новартис Аг Способ получения содержащей сквален эмульсии масла
CA2782511C (en) 2009-12-03 2013-11-12 Novartis Ag Circulation of components during homogenization of emulsions
DE102009056884B4 (de) 2009-12-03 2021-03-18 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
CN102740832B (zh) 2009-12-03 2016-01-13 诺华股份有限公司 就微流化排列交互作用和背压室
DE102009056871A1 (de) 2009-12-03 2011-06-22 Novartis AG, 4056 Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
DE102009056883B4 (de) 2009-12-03 2012-08-16 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
EA201290590A1 (ru) * 2010-01-27 2013-03-29 Глаксосмитклайн Байолоджикалс С.А. Модифицированные туберкулезные антигены
ES2597158T5 (es) * 2010-05-12 2020-03-26 Novartis Ag Procedimientos mejorados para preparar escualeno
GB201009671D0 (en) * 2010-06-10 2010-07-21 Glaxosmithkline Biolog Sa Novel process
GB201009673D0 (en) * 2010-06-10 2010-07-21 Glaxosmithkline Biolog Sa Novel process
GB201009676D0 (en) * 2010-06-10 2010-07-21 Glaxosmithkline Biolog Sa Novel process
EP2584904B1 (en) 2010-06-25 2019-01-09 Syngenta Participations AG Methods for controlling mites
WO2013132041A2 (en) 2012-03-08 2013-09-12 Novartis Ag Adjuvanted formulations of booster vaccines
AU2013311702A1 (en) 2012-09-06 2015-02-19 Novartis Ag Combination vaccines with serogroup B meningococcus and D/T/P
EP3620172A1 (en) 2012-10-12 2020-03-11 GlaxoSmithKline Biologicals SA Non-cross-linked acellular pertussis antigens for use in combination vaccines
JP2016502994A (ja) 2012-12-18 2016-02-01 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ジフテリア及び／又は破傷風から防御するためのコンジュゲート
EP3511020B1 (en) 2014-12-02 2021-01-20 Novartis AG Manufacture of surfactant-containing compositions
CN104531349A (zh) * 2015-01-23 2015-04-22 上海交通大学 一种降低油脂加工中3-氯-1,2-丙二醇酯的方法
CA3026108A1 (en) 2016-06-10 2017-12-14 Clarity Cosmetics Inc. Non-comedogenic hair and scalp care formulations and method for use
KR101717281B1 (ko) * 2016-08-19 2017-03-16 제주대학교 산학협력단 스쿠티카증에 대한 어류 복합 백신 조성물
CN107462729B (zh) * 2017-08-10 2018-11-23 迈克生物股份有限公司 一种载脂蛋白a1检测试剂盒及检测方法
CN107462730B (zh) * 2017-08-10 2018-10-12 迈克生物股份有限公司 一种补体c4检测试剂盒及检测方法
US20230218526A1 (en) 2020-06-30 2023-07-13 Seqirus UK Limited Cold filtration of oil-in-water emulsion adjuvants
CN112213438A (zh) * 2020-10-12 2021-01-12 青岛易邦生物工程有限公司 一种灭活疫苗佐剂白油检验方法
CN113842455B (zh) * 2021-08-27 2022-05-13 北京康乐卫士生物技术股份有限公司 一种新型冠状病毒疫苗的佐剂及其应用和新型冠状病毒二价重组疫苗

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU212924B (en) * 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
US5718904A (en) * 1995-06-02 1998-02-17 American Home Products Corporation Adjuvants for viral vaccines
EP1006999A2 (en) * 1997-07-08 2000-06-14 Chiron Corporation Use of submicron oil-in-water emulsions with dna vaccines
BR0014285A (pt) 1999-09-24 2002-05-21 Smithkline Beecham Biolog Adjuvantes compreendendo um éster ou éter de alquila de polioxietileno e pelo menos um tensoativo não-iÈnico
GB9923176D0 (en) * 1999-09-30 1999-12-01 Smithkline Beecham Biolog Novel composition
CA2423610A1 (en) * 2000-10-02 2002-04-11 Glaxosmithkline Biologicals S.A. Split enveloped virus preparation
US6861410B1 (en) * 2002-03-21 2005-03-01 Chiron Corporation Immunological adjuvant compositions
GB0428394D0 (en) * 2004-12-24 2005-02-02 Chiron Srl Saccharide conjugate vaccines
KR20070116650A (ko) 2005-03-23 2007-12-10 글락소스미스클라인 바이오로지칼즈 에스.에이. 조성물
AR054822A1 (es) 2005-07-07 2007-07-18 Sanofi Pasteur Emulsion inmuno adyuvante
GB0622282D0 (en) * 2006-11-08 2006-12-20 Novartis Ag Quality control methods

Also Published As

Publication number Publication date
CN101534856A (zh) 2009-09-16
EP2218460A2 (en) 2010-08-18
EP2218460A3 (en) 2012-08-29
GB0622282D0 (en) 2006-12-20
US9744231B2 (en) 2017-08-29
ATE446770T1 (de) 2009-11-15
BRPI0718858A2 (pt) 2014-02-04
DE602007003021D1 (de) 2009-12-10
SI2029170T1 (sl) 2010-02-26
US20140178428A1 (en) 2014-06-26
EP2029170B1 (en) 2009-10-28
DK2029170T3 (da) 2010-02-01
AU2007319006B2 (en) 2011-04-14
CA2668854A1 (en) 2008-05-15
ES2335160T3 (es) 2010-03-22
MX2009004697A (es) 2009-05-21
JP2010509202A (ja) 2010-03-25
US8562943B2 (en) 2013-10-22
WO2008056263A2 (en) 2008-05-15
IL198084A0 (en) 2011-08-01
RS51214B (sr) 2010-12-31
AU2007319006A1 (en) 2008-05-15
NO20092137L (no) 2009-07-31
ZA200902870B (en) 2010-03-31
KR20090083448A (ko) 2009-08-03
US20090291103A1 (en) 2009-11-26
EP2029170A2 (en) 2009-03-04
CA2668854C (en) 2019-06-04
PL2029170T3 (pl) 2010-04-30
HRP20100046T1 (hr) 2010-03-31
EA200900665A1 (ru) 2009-12-30
PT2029170E (pt) 2010-01-25
WO2008056263A3 (en) 2008-12-31
HK1126148A1 (en) 2009-08-28

Similar Documents

Publication Publication Date Title
CY1110248T1 (el) Μεθοδοι ελεγχου ποιοτητας για γαλακτωματα ελαιου εντος υδατος που περιεχουν σκουaλενιο
Köhler et al. Upgrading coagulation with hollow-fibre nanofiltration for improved organic matter removal during surface water treatment
DE112006004263A5 (de) Verfahren und Vorrichtung zum Stapeln von DRAMS
DE102005047413B8 (de) Magnetfeldsensorelement und Verfahren zum Durchführen eines On-Wafer-Funktionstests, sowie Verfahren zur Herstellung von Magnetfeldsensorelementen und Verfahren zur Herstellung von Magnetfeldsensorelementen mit On-Wafer-Funktionstest
BRPI0910369A2 (pt) "simulador de dessalinizador dinâmico para a realização de testes e método de realização de testes de produtos químicos quebradores de emulsão em um simulador de dessalinizador dinâmico"
DE112012005554A5 (de) Vorrichtung und Verfahren zum Erkennen von Fehlstellen innerhalb des Volumens einer ltransparenten Scheibe und Verwendung der Vorrichtung
GB0625393D0 (en) Apparatus and method for measuring the coagulation characteristics of a test liqid
DE602005018530D1 (de) Verfahren zum nachweis von mikro-rna-molekülen
DE602006020904D1 (de) Verfahren zum testen von antigen
DE602007001103D1 (de) Verfahren zur identifizierung von lrrk2 interagierenden molekülen und zur reinigung von lrrk2
DE602006008063D1 (de) Methode und Apparat zur Messung von Eigenschaften der Tränenflüssigkeit
EP2281186A4 (en) DEVICE AND METHOD FOR OPTICALLY DETECTING THE CONCENTRATION OF AN ANALYTE IN A FLUID CONTAINING ERYTHROCYTES
WO2009124649A3 (de) Verfahren sowie messeinrichtung zur bestimmung des gehalts an wenigstens einem filterhilfsmittel in einem flüssigen medium
DE502005002994D1 (de) Verfahren und Vorrichtung zum Bestimmen der Konzentrationen von mindestens zwei Liganden
EE05622B1 (et) Seade ja meetod bioloogilises vedelikus sisalduvate ainete kontsentratsiooni m??tmiseks
ATE346293T1 (de) Analytisches verfahren und vorrichtung zur bestimmung der metallkonzentration in flüssigen kohlenwasserstoffen
ATE555064T1 (de) Verfahren zum entkeimen von flüssigkeiten und flüssigkeitsentkeimungsvorrichtung
ZA200805396B (en) Apparatus for determining the presence of a contaminant in a sample of water or other fluid
WO2008084600A1 (ja) 波長特定方法および分析装置
DE602005013215D1 (de) Hydrokrackverfahren zum Erzeugen von Diesel mit extrem niedrigem Schwefelgehalt
DE502007004383D1 (de) Vorrichtung zum Erkennen und Ausscheiden von Fremdstoffen
ATE531823T1 (de) Verfahren zur erkennung eines trainingsinduzierten kollapses bei hunden
DE602006005071D1 (de) Verfahren und Vorrichtung zum Erkennen von eine gefährliche Substanz enthaltendem Postgut mittels Transmission
WO2008035309A3 (en) Method for identifying compounds that act as insulin-sensitizers
ATE403141T1 (de) Verfahren und vorrichtung zur messung rheologischer stoffeigenschaften einer visko- elastischen probe.